regeneron_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
| Date of
Report (Date of earliest event reported): February 16, 2010 (February 11,
2010) |
| REGENERON PHARMACEUTICALS,
INC. |
| (Exact Name of
Registrant as Specified in
Charter) |
| New York |
|
000-19034 |
|
13-3444607 |
| (State or other jurisdiction of |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
| Incorporation) |
|
|
|
|
| 777 Old Saw Mill River Road, Tarrytown, New
York 10591-6707 |
| (Address of principal executive offices,
including zip code) |
| |
| (914)
347-7000 |
| (Registrant's
telephone number, including area code)
|
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following
provisions:
| c |
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
|
|
| c |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
|
|
| c |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
| c |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement.
On February 11, 2010, Regeneron
Pharmaceuticals, Inc. (the “Company”) entered into a Fifth Amendment to Lease
(the “Amendment”), amending an operating lease agreement (the “Lease”), entered
into on December 21, 2006, with BioMed Realty Trust, Inc (“BMR”) for a corporate
headquarters and research laboratories in the Town of Greenburgh in Westchester
County, New York. The Amendment sets forth new terms for the payment by BMR to
the Company of tenant improvement allowances and the repayment of such
amounts by the Company as rent over the term of the Lease in accordance with the
Amendment.
The foregoing description of the Amendment is
qualified in its entirety by the full text of the Amendment which is filed as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Fifth Amendment to Lease dated as of February 11, 2010.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
| Date: February 16, 2010 |
REGENERON PHARMACEUTICALS,
INC. |
| |
| |
| |
By: |
/s/ Stuart
Kolinski |
| |
|
Name: Stuart Kolinski |
| |
|
Title: Senior Vice President and General
Counsel |
3
Exhibit Index
| Number |
|
Description |
| 99.1 |
|
Fifth Amendment to Lease dated as of
February 11, 2010. |
4